Phenylketonuria (PKU) produces no visible symptoms at birth. Babies with PKU appear completely healthy in their first weeks of life, which is why newborn screening catches the condition before damage begins. When PKU goes undetected or untreated, symptoms emerge gradually, starting around 3 to 6 months of age, and range from subtle cognitive differences to severe intellectual disability depending on how much phenylalanine builds up in the blood.
Why PKU Causes Symptoms
PKU prevents the body from properly breaking down phenylalanine, an amino acid found in most protein-rich foods. Normally, an enzyme converts phenylalanine into tyrosine, another amino acid the body needs. In PKU, that enzyme is missing or barely functional, so phenylalanine accumulates in the blood and brain while tyrosine runs low.
The brain is especially vulnerable to this imbalance. High phenylalanine acts as a neurotoxin, triggering oxidative stress that damages proteins, fats, and DNA in brain cells. Brain tissue is more susceptible to this kind of damage than other organs because it consumes large amounts of oxygen and has relatively weak antioxidant defenses. At the same time, the shortage of tyrosine starves the brain of raw material it needs to produce dopamine, norepinephrine, and adrenaline, three chemical messengers critical for attention, mood, and motivation. Tyrosine is also the starting ingredient for melanin, the pigment that colors skin, hair, and eyes, which explains some of PKU’s most visible physical signs.
Early Signs in Infants
Newborns with PKU look and behave normally. The first hints of trouble typically appear between 3 and 6 months, when an untreated baby begins to lose interest in their surroundings. By age 1, developmental delays become noticeable. The earliest physical signs parents or doctors may spot include:
- A musty or mousy odor on the skin, breath, or in urine, caused by excess phenylalanine breaking down into byproducts the body excretes
- Unusually fair skin, light hair, and blue eyes that stand out from the rest of the family, because low tyrosine means the body can’t produce enough melanin
- Eczema-like skin rashes that may appear in the first year
- Developmental delays in sitting, crawling, babbling, or responding to caregivers
These signs were once the way PKU was discovered. Today, newborn blood spot screening catches it long before symptoms appear. The test is done between 24 and 48 hours after birth, and thirteen states require a second screen at 1 to 2 weeks. Normal blood phenylalanine is below 2.0 mg/dL. Classic PKU is diagnosed when levels rise above 20 mg/dL on a normal diet.
Neurological Symptoms Without Treatment
When PKU goes completely untreated, the neurological consequences are severe. Persistent high phenylalanine damages the brain’s white matter, the insulation surrounding nerve fibers that allows signals to travel quickly. This leads to a condition called hypomyelination, where nerve pathways never develop their protective coating properly. Structural changes also appear in deep brain regions and the band of tissue connecting the two brain hemispheres.
The result, in most untreated cases, is significant intellectual disability, often accompanied by seizures, tremors, and hyperactivity. Microcephaly (an abnormally small head) can develop as brain growth falls behind. That said, the severity varies. A small number of people with untreated PKU have reached adulthood without seizures or measurable intellectual disability, though they remain the exception rather than the rule.
Cognitive Effects in Treated Adults
Early dietary treatment dramatically changes the picture. People diagnosed through newborn screening and started on a low-phenylalanine diet in infancy generally develop normal or near-normal intelligence. Learning abilities tend to be well preserved. But even with good treatment, subtle cognitive differences often persist into adulthood.
The most consistent finding across studies is slower processing speed. Adults with PKU take measurably longer to complete cognitive tasks, with the difference falling in the medium range on standardized scales. This isn’t about motor speed; their physical reaction times are normal. The slowdown is purely mental, showing up when tasks require thinking through information quickly.
Complex executive functions are the other area where differences appear. These are higher-order thinking skills: planning several steps ahead, switching flexibly between strategies, and monitoring your own performance over time. Adults with PKU tend to score lower on tasks that require planning and cognitive flexibility. Sustained attention, the ability to stay focused over long stretches, is also often impaired. Working memory tasks show mainly a speed deficit rather than an accuracy problem. In practical terms, these differences might look like difficulty staying on task during long projects, taking longer to organize complex plans, or feeling mentally fatigued more easily than peers.
Behavioral and Psychiatric Symptoms
PKU raises the risk of several psychiatric conditions across the lifespan. Mood disorders, anxiety, and attention problems are the most commonly reported. ADHD occurs at roughly twice the rate in people with PKU compared to the general population, with the inattentive presentation being particularly common. Both children and adults can display a wide range of emotional and behavioral difficulties, and the severity correlates strongly with how well phenylalanine levels have been controlled and when any lapses in diet occurred.
In cases of very poor or absent dietary control, the psychiatric picture can be more severe. There is notable overlap between the brain chemistry disruptions in PKU and those seen in psychotic disorders, which accounts for higher rates of psychosis observed in some untreated populations. Depression and anxiety are common even in well-treated adults, particularly those who have relaxed their diet over time.
Risks During Pregnancy
Women with PKU face a specific set of risks if phenylalanine levels are high during pregnancy. Phenylalanine crosses the placenta freely, and levels in the developing fetus can actually climb higher than in the mother’s blood. This can cause damage even if the baby does not have PKU.
High maternal phenylalanine increases the chance of miscarriage and raises the risk of the baby being born with microcephaly, heart defects, and low birth weight. Children born to mothers with poorly controlled PKU have higher rates of intellectual disability, behavioral problems, and seizures. The timing of dietary control matters enormously: women who don’t resume strict phenylalanine restriction until after the first trimester have babies who score lower on developmental tests than those whose levels were controlled before conception. Medical guidelines recommend maintaining phenylalanine below 360 micromoles per liter before and throughout pregnancy. Interestingly, levels that are too low (below 100 micromoles per liter) can also cause fetal growth problems in the second and third trimesters, making careful monitoring essential.
Which Symptoms Improve With Treatment
One of the more encouraging findings in PKU research is that many symptoms are at least partially reversible when dietary control is resumed, even in adulthood. White matter damage visible on brain scans has been shown to improve with better phenylalanine control. Cognitive performance, particularly processing speed and executive function, tends to get better. In one twelve-month study of adults who returned to a strict PKU diet, participants showed measurable improvements in both cognitive functioning and clinical scores for depression and anxiety.
The relationship between phenylalanine levels and IQ has been quantified: for every 100 micromoles per liter increase in blood phenylalanine, IQ drops by an estimated 1.3 to 3.9 points in early-treated patients. This means the damage accumulates gradually with ongoing exposure, but it also means that tighter control can meaningfully protect cognitive ability over time. The takeaway is that dietary management matters at every age, not just during childhood brain development. Adults who have drifted away from their PKU diet and notice increased anxiety, low mood, or difficulty concentrating may see those symptoms improve by returning to tighter phenylalanine control.